Modulation of neuropeptide Y levels is impaired in crack withdrawal patients.

Introduction The dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has a key role in drug addiction susceptibility. In addition to the well-known relationship between cortisol and the HPA axis, other molecules are involved with stress response and could modify the HPA activation, such as the neuropeptide Y (NPY), which has anxiolytic proprieties. There are few studies evaluating the effect of NPY levels on addiction, especially in crack cocaine dependence. Objective To evaluate NPY in crack users during early withdrawal to determine its relationship with drug use and cortisol levels. Methods We analyzed 25 male inpatient crack users. Serum NPY levels were measured at admission and discharge (mean of 24 days). Morning salivary cortisol was measured at admission. Results Serum NPY levels at admission and discharge were very similar. Lower NPY levels at discharge were associated with higher lifetime crack use. Also, a negative correlation was found between morning cortisol and delta NPY (NPY discharge - NPY admission). Conclusion These preliminary findings indicate that crack use influences the modulation of NPY levels and modifies stress response. The NPY pathway may play an important role in the pathophysiology of crack addiction, and the anxiolytic effect of NPY may be impaired in crack users. Future studies should consider NPY as a measurable indicator of the biological state in addiction.

[1]  A. Torres-Berrío,et al.  Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience , 2018, Front. Psychol..

[2]  W. Colmers,et al.  NPY Induces Stress Resilience via Downregulation of Ih in Principal Neurons of Rat Basolateral Amygdala , 2018, The Journal of Neuroscience.

[3]  J. Godfrey,et al.  A Method for Psychosocial Stress-Induced Reinstatement of Cocaine Seeking in Rats , 2016, Biological Psychiatry.

[4]  Sara R. Jones,et al.  Effects of chronic ethanol exposure on neuronal function in the prefrontal cortex and extended amygdala , 2015, Neuropharmacology.

[5]  G. Sørensen,et al.  Mice lacking neuropeptide Y show increased sensitivity to cocaine , 2012, Synapse.

[6]  R. Hauger,et al.  Genetic modulation of plasma NPY stress response is suppressed in substance abuse: Association with clinical outcomes , 2012, Psychoneuroendocrinology.

[7]  A. Alterman,et al.  Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. , 2012, Revista brasileira de psiquiatria.

[8]  M. Javors,et al.  Serum NPY and BNDF response to a behavioral stressor in alcohol-dependent and healthy control participants , 2011, Psychopharmacology.

[9]  N. Gilpin,et al.  Effects of neuropeptide Y and ethanol on arousal and anxiety-like behavior in alcohol-preferring rats. , 2011, Alcohol.

[10]  Stacey B. Daughters,et al.  HPA axis response to psychological stress and treatment retention in residential substance abuse treatment: a prospective study. , 2009, Drug and Alcohol Dependence.

[11]  U. Shalev,et al.  Neuropeptide Y augments cocaine self-administration and cocaine-induced hyperlocomotion in rats , 2009, Peptides.

[12]  N. Gilpin,et al.  Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats. , 2008, Alcohol.

[13]  Rajita Sinha,et al.  Chronic Stress, Drug Use, and Vulnerability to Addiction , 2008, Annals of the New York Academy of Sciences.

[14]  K. Vrana,et al.  Persistent Alterations in Mesolimbic Gene Expression with Abstinence from Cocaine Self-Administration , 2008, Neuropsychopharmacology.

[15]  G. Koob,et al.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence. , 2007, The American journal of psychiatry.

[16]  R. Sinha,et al.  Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. , 2006, Archives of general psychiatry.

[17]  M. Newcomb,et al.  Development and validation of a brief screening version of the Childhood Trauma Questionnaire. , 2003, Child abuse & neglect.

[18]  Y. Shaham,et al.  The reinstatement model of drug relapse: history, methodology and major findings , 2003, Psychopharmacology.

[19]  Charles A Morgan,et al.  Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report , 2002, Biological Psychiatry.

[20]  S. Pandey,et al.  The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. , 2002, Alcoholism, clinical and experimental research.

[21]  J. Harro,et al.  The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y , 2002, Neuroscience & Biobehavioral Reviews.

[22]  D. Finn,et al.  Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus , 2000, Neuroreport.

[23]  A. Steiger,et al.  Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men , 2000, Neuropharmacology.

[24]  M. Kreek,et al.  Effects of cocaine self-administration on plasma corticosterone and prolactin in rats. , 2000, The Journal of pharmacology and experimental therapeutics.

[25]  G. Koob,et al.  Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze , 2000, Peptides.

[26]  C. Rivier,et al.  Stimulatory Effect of Cocaine on ACTH Secretion: Role of the Hypothalamus , 1994, Molecular and Cellular Neuroscience.

[27]  R. S. Sloviter,et al.  Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus; a silver degeneration and immunocytochemical study , 1993, Brain Research.

[28]  D. Larhammar,et al.  Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.